| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.953 | 27.516 | 98.437 | 84.430 | 120.129 | 101.295 | 110.290 | 118.111 | 134.841 | 184.718 |
| Total Income - EUR | 38.902 | 69.485 | 125.933 | 84.717 | 120.129 | 101.295 | 110.290 | 118.111 | 134.887 | 184.718 |
| Total Expenses - EUR | 30.818 | 66.198 | 98.749 | 80.470 | 70.602 | 58.705 | 69.634 | 63.116 | 99.914 | 135.507 |
| Gross Profit/Loss - EUR | 8.084 | 3.286 | 27.184 | 4.248 | 49.527 | 42.590 | 40.656 | 54.995 | 34.973 | 49.211 |
| Net Profit/Loss - EUR | 6.945 | 2.401 | 22.166 | 3.403 | 48.325 | 41.846 | 39.575 | 53.814 | 33.625 | 43.669 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Miremed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75.387 | 63.172 | 73.279 | 54.141 | 37.237 | 28.898 | 20.421 | 16.999 | 116.772 | 190.040 |
| Current Assets | 23.462 | 18.708 | 16.601 | 9.496 | 9.785 | 8.266 | 18.809 | 37.812 | 10.006 | 19.370 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.702 | 2.673 | 2.872 | 110 | 108 | 106 | 5 | 35.608 | 339 | 0 |
| Cash | 16.760 | 16.035 | 13.729 | 9.386 | 9.677 | 8.160 | 18.803 | 2.203 | 9.666 | 19.370 |
| Shareholders Funds | -570 | 1.838 | 22.219 | 23.191 | 48.376 | 41.896 | 39.624 | 53.863 | 42.656 | 86.087 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 110.701 | 85.460 | 76.682 | 46.517 | 4.772 | 1.277 | 2.806 | 2.249 | 84.122 | 123.322 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Miremed S.r.l.